IM Cannabis (IMCC) Prepaid Assets (2019 - 2026)

IM Cannabis (IMCC) posted quarterly Prepaid Assets of $3.5 million for Q1 2026, up 13.05% quarter-over-quarter from $3.1 million in Q4 2025.

IM Cannabis (IMCC) Prepaid Assets (2019 - 2026) Analysis & Trends

IM Cannabis' Prepaid Assets history runs 8 years deep, the most recent figure standing at $3.5 million for Q1 2026.

In Q1 2026, Prepaid Assets changed N/A year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (changed N/A YoY), while the FY2025 annual figure was $3.1 million, down 21.81% from the prior year.
Prepaid Assets for Q1 2026 stood at $3.5 million, up from $3.1 million in the prior quarter.
The five-year high for Prepaid Assets was $6.1 million in Q2 2025, with the low at $1.2 million in Q2 2022.
The 5-year median for Prepaid Assets is $3.5 million (2026), against an average of $3.6 million.
Peak annual rise in Prepaid Assets reached 37.96% in 2022, while the deepest fall reached 39.96% in 2022.
IM Cannabis' Prepaid Assets stood at $1.2 million in 2022, then jumped by 203.06% to $3.5 million in 2023, then grew by 9.45% to $3.9 million in 2024, then declined by 20.22% to $3.1 million in 2025, then climbed by 13.05% to $3.5 million in 2026.
Business Quant data shows IMCC's Prepaid Assets at $3.5 million in Q1 2026, $3.1 million in Q4 2025, and $5.9 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	IM Cannabis	554,496.00	-614,474.17	1.09 Mn

Download Data